Torthaí cuardaigh - Cheng‐Yuan Peng
- 1 - 20 toradh as 35 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy de réir Cheng‐Yuan Peng, Rong‐Nan Chien, Yun–Fan Liaw
Foilsithe / Cruthaithe 2012Revisão -
2
Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. de réir Min Xu, Kelly-Ann Sheppard, Cheng‐Yuan Peng, Amy S. Yee, Helen Piwnica‐Worms
Foilsithe / Cruthaithe 1994Artigo -
3
-
4
Interferon-alpha-induced depression: Comparisons between early- and late-onset subgroups and with patients with major depressive disorder de réir Kuan‐Pin Su, Hsueh‐Chou Lai, Cheng‐Yuan Peng, Wen‐Pang Su, Jane Pei‐Chen Chang, Carmine M. Pariante
Foilsithe / Cruthaithe 2019Artigo -
5
Single-cell RNA-seq landscape midbrain cell responses to red spotted grouper nervous necrosis virus infection de réir Qing Wang, Cheng‐Yuan Peng, Min Yang, Fengqi Huang, Xuzhuo Duan, Shaowen Wang, Huitao Cheng, Huirong Yang, Huihong Zhao, Qiwei Qin
Foilsithe / Cruthaithe 2021Artigo -
6
Effects of patient factors on noninvasive liver stiffness measurement using acoustic radiation force impulse elastography in patients with chronic hepatitis C de réir Sheng‐Hung Chen, Yufen Li, Hsueh‐Chou Lai, Jung‐Ta Kao, Cheng‐Yuan Peng, Po‐Heng Chuang, Wen‐Pang Su, I‐Ping Chiang
Foilsithe / Cruthaithe 2012Artigo -
7
Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids Levels de réir Kuan‐Pin Su, Shih‐Yi Huang, Cheng‐Yuan Peng, Hsueh‐Chou Lai, Chieh‐Liang Huang, Yi-Chih Chen, Katherine J. Aitchison, Carmine M. Pariante
Foilsithe / Cruthaithe 2009Artigo -
8
Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning de réir Runmin Wei, Jingye Wang, Xiaoning Wang, Guoxiang Xie, Yixing Wang, Hua Zhang, Cheng‐Yuan Peng, Cynthia Rajani, Sandi A. Kwee, Ping Liu, Wei Jia
Foilsithe / Cruthaithe 2018Artigo -
9
Omega-3 Fatty Acids in the Prevention of Interferon-Alpha-Induced Depression: Results from a Randomized, Controlled Trial de réir Kuan‐Pin Su, Hsueh‐Chou Lai, Hui-Ting Yang, Wen-Pang Su, Cheng‐Yuan Peng, Jane Pei‐Chen Chang, Hui-Chih Chang, Carmine M. Pariante
Foilsithe / Cruthaithe 2014Artigo -
10
Increased Incidence of Gastrointestinal Cancers Among Patients With Pyogenic Liver Abscess: A Population-Based Cohort Study de réir Hsueh‐Chou Lai, Che‐Chen Lin, Ken‐Sheng Cheng, Jung‐Ta Kao, Jen‐Wei Chou, Cheng‐Yuan Peng, Shih‐Wei Lai, Pei‐Chun Chen, Fung‐Chang Sung
Foilsithe / Cruthaithe 2013Artigo -
11
Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis de réir Ira M. Jacobson, Eric Lawitz, Paul Y. Kwo, Christophe Hézode, Cheng‐Yuan Peng, Anita Y. M. Howe, Peggy Hwang, Janice Wahl, Michael Robertson, Eliav Barr, Barbara Haber
Foilsithe / Cruthaithe 2017Artigo -
12
New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis de réir Hung‐Wei Wang, Cheng‐Yuan Peng, Hsueh-Chou Lai, Wen-Pang Su, Chia‐Hsin Lin, Po-Heng Chuang, Sheng-Hung Chen, Ching-Hsiang Chen, Wei‐Fan Hsu, Guan‐Tarn Huang
Foilsithe / Cruthaithe 2017Artigo -
13
Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents de réir Wei‐Fan Hsu, Hsueh‐Chou Lai, Wen‐Pang Su, Chia‐Hsin Lin, Po‐Heng Chuang, Sheng‐Hung Chen, Hung‐Yao Chen, Hung‐Wei Wang, Guan‐Tarn Huang, Cheng‐Yuan Peng
Foilsithe / Cruthaithe 2019Artigo -
14
Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir de réir Chien‐Hung Chen, Chuan-Mo Lee, Hsueh‐Chou Lai, Tsung‐Hui Hu, Wen-Pang Su, Sheng‐Nan Lu, Chia‐Hsin Lin, Chao‐Hung Hung, Jing‐Houng Wang, Mei–Hsuan Lee, Cheng‐Yuan Peng
Foilsithe / Cruthaithe 2017Artigo -
15
Efficacy and safety of entecavir versus adefovir in chronic hepatitis B patients with hepatic decompensation: A randomized, open-label study de réir Yun–Fan Liaw, M. Raptopoulou‐Gigi, Hugo Cheinquer, Shiv Kumar Sarin, Tawesak Tanwandee, Nancy Leung, Cheng‐Yuan Peng, Robert P. Myers, Robert S. Brown, Lennox J. Jeffers, Naoky Tsai, Jolanta Białkowska, Shijie Tang, S. P. Beebe, Elizabeth Cooney
Foilsithe / Cruthaithe 2011Artigo -
16
Comorbidities, concomitant medications and potential drug‐drug interactions with interferon‐free direct‐acting antiviral agents in hepatitis C patients in Taiwan de réir Chen‐Hua Liu, Ming‐Lung Yu, Cheng‐Yuan Peng, Tsai‐Yuan Hsieh, Yi‐Hsiang Huang, Wei‐Wen Su, Pin‐Nan Cheng, Chih‐Lin Lin, Gin‐Ho Lo, Chi‐Yi Chen, Jyh‐Jou Chen, Qian Ma, C. Brooks-Rooney, Jia‐Horng Kao
Foilsithe / Cruthaithe 2018Artigo -
17
Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion de réir Hung‐Chih Yang, Chi‐Ling Chen, Yueh-Chi Shen, Cheng‐Yuan Peng, Chun‐Jen Liu, Tai–Chung Tseng, Tung‐Hung Su, Wan‐Long Chuang, Ming‐Lung Yu, Chia‐Yen Dai, Chen‐Hua Liu, Pei‐Jer Chen, Ding‐Shinn Chen, Jia‐Horng Kao
Foilsithe / Cruthaithe 2012Artigo -
18
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection de réir Paul Y. Kwo, Edward Gane, Cheng‐Yuan Peng, Brian L. Pearlman, John M. Vierling, Lawrence Serfaty, Marı́a Buti, Stephen D. Shafran, Paul Stryszak, Lin Li, Jacqueline Gress, Stuart Black, Frank J. Dutko, Michael Robertson, Janice Wahl, Lisa Lupinacci, Eliav Barr, Barbara Haber
Foilsithe / Cruthaithe 2016Artigo -
19
2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations de réir Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, Tsung‐Hui Hu, Chung‐Feng Huang, Yi‐Hsiang Huang, Chao‐Hung Hung, Chun‐Yen Lin, Chen‐Hua Liu, Chun‐Jen Liu, Cheng‐Yuan Peng, Han‐Chieh Lin, Jia‐Horng Kao, Wan‐Long Chuang
Foilsithe / Cruthaithe 2020Artigo -
20
2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population de réir Ming‐Lung Yu, Pei‐Jer Chen, Chia‐Yen Dai, Tsung‐Hui Hu, Chung‐Feng Huang, Yi‐Hsiang Huang, Chao‐Hung Hung, Chun‐Yen Lin, Chen‐Hua Liu, Chun‐Jen Liu, Cheng‐Yuan Peng, Han‐Chieh Lin, Jia‐Horng Kao, Wan‐Long Chuang
Foilsithe / Cruthaithe 2020Revisão
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
Virus
Gastroenterology
Immunology
Virology
Hepatocellular carcinoma
Hepatitis B virus
Hepatitis C
Cirrhosis
Chronic hepatitis
Hepatitis B
Hepatitis C virus
Entecavir
Lamivudine
Biology
Confidence interval
HBsAg
Biochemistry
Hepatology
Oncology
Receiver operating characteristic
Environmental health
HBeAg
Hepatitis
Interferon
Pharmacology
Population
Randomized controlled trial
Ribavirin